Malignant Salivary Gland Tumors in Quito, Ecuador
Openalex
Resumen
The surgical or multimodality treatment of MSGT has provided a good locoregional control (78%) and 68% 10-year survival in a series of patients treated at the oncology department of a general hospital in Quito, Ecuador. Stage and involved surgical margins were significant prognostic factors.
Cómo citar
Luis Pacheco‐Ojeda, & Hannes Domeisen, & Mercedes Narvaez, & Ricardo Tixi, & Nicolás Vivar (2000). Malignant Salivary Gland Tumors in Quito, Ecuador. https://doi.org/10.1159/000027772